Previous Close | 3.7200 |
Open | 3.7200 |
Bid | 3.6700 x N/A |
Ask | 3.8100 x N/A |
Day's Range | 3.7200 - 3.7200 |
52 Week Range | 3.3500 - 8.0000 |
Volume | |
Avg. Volume | 266 |
Market Cap | 169.53M |
Beta (5Y Monthly) | -0.21 |
PE Ratio (TTM) | 16.91 |
EPS (TTM) | 0.2200 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for INCR-U.TO
Leading Global Pharmaceutical Cannabis Company, InterCure, entered into an agreement with Praetorian Global, Inc. to license, manufacture and distribute the Florida-based cannabis brand ”Binske”NEW YORK and TORONTO and HERZLIYA, Israel, Dec. 19, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the largest and fastest growing medical cannabis company outside of North America, today announced that it has entered into a
Mr. Rabinovitch is one of the global cannabis senior executives to participateNEW YORK and TORONTO and HERZLIYA, Israel, Dec. 08, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that Alexander Rabinovitch, CEO of InterCure, will participate in Cowen 5th Annual Cannabis Conference, taking place December 8th, 2022. Mr. Rabinovitch will take part in the industry leaders panel on Thursday, December 8th, 202
NEW YORK and TORONTO and HERZLIYA, Israel, Dec. 05, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company") is pleased to announce the withdrawal of a class action lawsuit against it (the “Regenera Lawsuit”). The Regenera Lawsuit was described in the Company’s press release dated May 26, 2020 and in the Company's most recent Annual Report and Annual Information Form and it was primarily concerning a motion to certify, as a cl